Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IFF third quarter

Executive Summary

Fueled by growth in North America and Europe, worldwide fragrance sales increased 5% in dollars during the third quarter on pro forma basis, fragrance and flavor supplier announces in 1Oct. 24 release. North American fragrance sales grew 2%, as fine perfumery and aromachemicals each increased in "high single-digits." European fragrance sales up 8% in local currency, with 25% local currency fine fragrances gain based on new wins and pick-up in travel retail. Global flavor sales rose 5% in the quarter, contributing to 5% consolidated sales increase to $462.8 mil. versus comparable 2001 results. Net income up 18% to $49.6 mil., excluding nonrecurring charges. Integration of Bush Boake Allen completed during the quarter, IFF announces, providing savings "run rate" of $80 mil., ahead of plan. Firm projects Q4 consolidated dollar sales to increase in low single-digits, earnings per share to rise 8%-12%, excluding charges...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS010703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel